Warning: The NCBI web site requires JavaScript to function. more...
Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.
Lackner P, Part A, Burger C, Dietmann A, Broessner G, Helbok R, Reindl M, Schmutzhard E, Beer R.
Malar J. 2009 Feb 27;8:36.
Related citations
Early cytokine production is associated with protection from murine cerebral malaria.
Mitchell AJ, Hansen AM, Hee L, Ball HJ, Potter SM, Walker JC, Hunt NH.
Infect Immun. 2005 Sep;73(9):5645-53.
Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.
Wiese L, Hempel C, Penkowa M, Kirkby N, Kurtzhals JA.
Malar J. 2008 Jan 7;7:3.
Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.
Lackner P, Hametner C, Beer R, Burger C, Broessner G, Helbok R, Speth C, Schmutzhard E.
Malar J. 2008 Oct 10;7:207.
Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host.
Griffith JW, O'Connor C, Bernard K, Town T, Goldstein DR, Bucala R.
J Infect Dis. 2007 Nov 15;196(10):1553-64. Epub 2007 Oct 31.
Co-infection with Trypanosoma cruzi protects mice against early death by neurological or pulmonary disorders induced by Plasmodium berghei ANKA.
Egima CM, Macedo SF, Sasso GR, Covarrubias C, Cortez M, Maeda FY, Costa FT, Yoshida N.
Malar J. 2007 Jul 9;6:90.
IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.
Niikura M, Kamiya S, Nakane A, Kita K, Kobayashi F.
Int J Parasitol. 2010 Jan;40(1):101-8. Epub 2009 Sep 6.
Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice.
Vigário AM, Belnoue E, Grüner AC, Mauduit M, Kayibanda M, Deschemin JC, Marussig M, Snounou G, Mazier D, Gresser I, Rénia L.
J Immunol. 2007 May 15;178(10):6416-25.
Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria.
McQuillan JA, Mitchell AJ, Ho YF, Combes V, Ball HJ, Golenser J, Grau GE, Hunt NH.
Int J Parasitol. 2011 Feb;41(2):155-63. Epub 2010 Sep 7.
Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice.
Curfs JH, van der Meide PH, Billiau A, Meuwissen JH, Eling WM.
Exp Parasitol. 1993 Sep;77(2):212-23.
Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
Lepenies B, Pfeffer K, Hurchla MA, Murphy TL, Murphy KM, Oetzel J, Fleischer B, Jacobs T.
J Immunol. 2007 Sep 15;179(6):4093-100.
Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain.
Hanum P S, Hayano M, Kojima S.
Int Immunol. 2003 May;15(5):633-40.
Malaria and obesity: obese mice are resistant to cerebral malaria.
Robert V, Bourgouin C, Depoix D, Thouvenot C, Lombard MN, Grellier P.
Malar J. 2008 May 19;7:81.
Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice.
Delahaye NF, Coltel N, Puthier D, Barbier M, Benech P, Joly F, Iraqi FA, Grau GE, Nguyen C, Rihet P.
BMC Genomics. 2007 Dec 6;8:452.
Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice.
Ohno T, Kobayashi F, Nishimura M.
Immunogenetics. 2005 May;57(3-4):293-6. Epub 2005 Apr 2.
MDR1A (ABCB1)-deficient CF-1 mutant mice are susceptible to cerebral malaria induced by Plasmodium berghei ANKA.
de Lagerie SB, Fernandez C, German-Fattal M, Gantier JC, Gimenez F, Farinotti R.
J Parasitol. 2008 Oct;94(5):1139-42.
Hyperbaric oxygen prevents early death caused by experimental cerebral malaria.
Blanco YC, Farias AS, Goelnitz U, Lopes SC, Arrais-Silva WW, Carvalho BO, Amino R, Wunderlich G, Santos LM, Giorgio S, Costa FT.
PLoS One. 2008 Sep 4;3(9):e3126.
Comparative study of brain CD8+ T cells induced by sporozoites and those induced by blood-stage Plasmodium berghei ANKA involved in the development of cerebral malaria.
Bagot S, Nogueira F, Collette A, do Rosario V, Lemonier F, Cazenave PA, Pied S.
Infect Immun. 2004 May;72(5):2817-26.
CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-gamma-induced chemokines.
Van den Steen PE, Deroost K, Van Aelst I, Geurts N, Martens E, Struyf S, Nie CQ, Hansen DS, Matthys P, Van Damme J, Opdenakker G.
Eur J Immunol. 2008 Apr;38(4):1082-95.
Cytokine profile suggesting that murine cerebral malaria is an encephalitis.
Jennings VM, Actor JK, Lal AA, Hunter RL.
Infect Immun. 1997 Nov;65(11):4883-7.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on